StemRIM Management
Management criteria checks 2/4
StemRIM's CEO is Masatsune Okajima, appointed in Mar 2019, has a tenure of 5.17 years. total yearly compensation is ¥177.56M, comprised of 16.9% salary and 83.1% bonuses, including company stock and options. directly owns 0.41% of the company’s shares, worth ¥120.98M. The average tenure of the management team and the board of directors is 2.9 years and 4.6 years respectively.
Key information
Masatsune Okajima
Chief executive officer
JP¥177.6m
Total compensation
CEO salary percentage | 16.9% |
CEO tenure | 5.2yrs |
CEO ownership | 0.4% |
Management average tenure | 2.9yrs |
Board average tenure | 4.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jan 31 2024 | n/a | n/a | JP¥179m |
Oct 31 2023 | n/a | n/a | JP¥214m |
Jul 31 2023 | JP¥178m | JP¥30m | JP¥168m |
Compensation vs Market: Masatsune's total compensation ($USD1.16M) is above average for companies of similar size in the JP market ($USD842.11K).
Compensation vs Earnings: Insufficient data to compare Masatsune's compensation with company performance.
CEO
Masatsune Okajima (55 yo)
5.2yrs
Tenure
JP¥177,557,000
Compensation
Mr. Masatsune Okajima serves as the Chief Executive Officer at StemRIM since October 2023. He has been the President at StemRIM since March 2019 and its Representative Director and served as its Chief Oper...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 10.8yrs | JP¥124.13m | 8.15% ¥ 2.4b | |
President | 5.2yrs | JP¥177.56m | 0.41% ¥ 121.0m | |
Chief Scientific Officer | less than a year | no data | 15.78% ¥ 4.6b | |
Head of Drug Discovery | 5.3yrs | no data | 3.98% ¥ 1.2b |
2.9yrs
Average Tenure
59yo
Average Age
Experienced Management: 4599's management team is considered experienced (2.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 10.8yrs | JP¥124.13m | 8.15% ¥ 2.4b | |
President | 5.2yrs | JP¥177.56m | 0.41% ¥ 121.0m | |
Chief Scientific Officer | 1.6yrs | no data | 15.78% ¥ 4.6b | |
Independent Outside Director | 4.6yrs | no data | 0.0049% ¥ 1.4m | |
Full-Time External Audit & Supervisory Board Member | 6.6yrs | no data | 0.083% ¥ 24.2m | |
External Audit & Supervisory Board Member | 4.6yrs | no data | 0.092% ¥ 26.8m | |
External Audit & Supervisory Board Member | 4.6yrs | no data | 0.019% ¥ 5.5m | |
Independent Outside Director | 3.6yrs | no data | 0.0049% ¥ 1.4m |
4.6yrs
Average Tenure
65yo
Average Age
Experienced Board: 4599's board of directors are considered experienced (4.6 years average tenure).